Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Taiwan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20172
20182
20192
20203
20214
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting4
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Eli Lilly and Company2
AbGenomics B.V Taiwan Branch1
AbbVie1
Acepodia Biotech, Inc.1
Astellas Pharma Global Development, Inc.1
China Medical University Hospital1
Impact Therapeutics, Inc.1
LaunXP Biomedical Co., Ltd.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms19
Colorectal Neoplasms7
Neoplasms7
Ovarian Neoplasms6
Stomach Neoplasms6
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung5
Endometrial Neoplasms4
Esophageal Neoplasms4
Lung Neoplasms3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.